Recent Post
Dear Doctor, how’s your blood pressure?
Concerningly, Australian GPs may be inadvertently placing themselves at increased risk of heart attack and stroke, according to new findings from the GP Health Initiative Report released this week, revealing one in seven (14%) GP respondents are not self-monitoring their blood pressure (BP) each year. According to the Servier-commissioned, quantitative, online survey conducted by Metis…
Read MoreCelebrating 21 years of protecting Aussie bones in partnership with Healthy Bones Australia
Yesterday, our team at VIVA! Communications had the privilege of partnering with Healthy Bones Australia to celebrate their 21 years of protecting Aussie bones. We coordinated a national news media announcement to mark this significant milestone, and announced the organisation’s new partnership with an Australian company to develop a breakthrough diagnostic fracture prediction tool. We…
Read More
First treatment in 10 years PBS listed for Aussies
living with aggressive stomach & oesophageal cancers
Australians living with types of aggressive stomach or oesophageal cancers can now access immunotherapy on the Pharmaceutical Benefits Scheme (PBS), representing the first treatment advance for many of these patients in a decade. OPDIVO® (nivolumab) in combination with chemotherapy, is now reimbursed as an initial treatment for patients with a type of stomach or oesophageal…
Read More9 in 10 Australians with deadly heart valve disease not undergoing treatment
Non-surgical treatment now available on Medicare Of the estimated 66,500 Australians living with aortic stenosis, 9 in 10 are not undergoing treatment each year for the potentially life-threatening disease. However, the inclusion of transcatheter aortic valve implantation (TAVI) on Medicare from July 1, 2022, is expanding access to the minimally invasive treatment option for all…
Read MoreAussie men with advanced prostate cancer denied access to innovative treatment on Medicare
Almost 20,000 Australian men diagnosed each year with prostate cancer are being denied access to an innovative treatment on Medicare for the nation’s most common cancer in men. Two treatment options – low dose rate brachytherapy (LDR-brachytherapy) and external beam radiation therapy – are approved to treat prostate cancer in Australia by the medical regulator,…
Read More